New particles aim to shrink fibroids without surgery

NCT ID NCT06153667

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing Bearing nsPVA particles, used during a procedure called uterine artery embolization, to treat uterine fibroids in 100 women. The goal is to see if these particles safely block blood flow to fibroids, reducing symptoms like pain and heavy bleeding. Participants will be followed for 6 months to check for serious side effects and improvement in quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UTERINE FIBROID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

leiomyoma uterine corpus leiomyoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Alfred Health

    RECRUITING

    Sydney, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Astra Vascular/Astra Vein Treatment Center

    ACTIVE_NOT_RECRUITING

    Brooklyn, New York, 11234, United States

  • Royal Gwent Hospital (Aneurin Bevan UHB)

    RECRUITING

    Newport, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Wesley Hospital

    RECRUITING

    Brisbane, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••